← SynDRA
AMIKACIN
SynDRA canonical compound SYN0006026 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | bacterial 30S ribosomal subunit inhibitor |
| Indication | gram-negative bacterial infections |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
- bacterial 30S ribosomal subunit inhibitor
- Stap-coc pbp2 BINDER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR1
- ACHE
- MAPK1
- NR1I2
- NPY2R
- NPY1R
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAOA
- HMGCR
- LMNA
- LCK
- KCNH2
- KAT2A
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH2
- NR3C1
- OPRD1
- OPRK1
- SIGMAR1
- TERT
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ATRX
- CRHBP
- CRHR2
- MLLT3
- RGAP1
- SAE1
- UBA2
Drug classes
- Aminoglycoside Antibacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- S01A · ANTIINFECTIVES
- D06A · ANTIBIOTICS FOR TOPICAL USE
- J01G · AMINOGLYCOSIDE ANTIBACTERIALS
- COMBINATIONS OF ANTIBACTERIALS
Cross-references
Synonyms
- AMIKACIN SULFATE
- AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- AMIKIN
- AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- ARIKAYCE KIT
- Arikayce
- amicacin
- amikacillin
- arikace
- lukadin
- amikacin sulfate
- amikacin hydrate
- Amikacine
- Amikacina
- Amikacinum
- Lukadin
- Potentox
- BAY 41-6551
- NSC-177001
- Amicacin
- Amikavet
- Amikin
- Arikace
- Briclin
- Kaminax
- Mikavir
- Amikacin Base
- Amikacin Dihydrate
- ANTIBIOTIC BB-K8
- Amiglyde-V
- Amikacin & Tumor Necrosis Factor
- Amikacin (USP)
- Amikacina [INN-Spanish]
- Amikacine [INN-French]
- Amikacinum [INN-Latin]
- Amikin(Disulfate)
- Antibiotic BB-K 8
- BB-K 8
Reported adverse events
- Rash
- Vomiting
- Nausea
- Pyrexia
- Anxiety
- Bronchitis
- Bronchospasm
- Chest discomfort
- Cough
- Dry mouth
- Dysgeusia
- Dysphonia
Look up AMIKACIN in the interactive SynDRA portal →